IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?

A. Haccuria (Brussels, Belgium)

Source: International Congress 2017 – Monitoring asthma control
Session: Monitoring asthma control
Session type: Poster Discussion
Number: 4767
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Haccuria (Brussels, Belgium). IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?. 4767

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES)
Source: Eur Respir J 2001; 18: Suppl. 33, 529s
Year: 2001

Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016


Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001

Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 734s
Year: 2005

Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 735s
Year: 2005

Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Montelukast reduces Th2 type cytokines in induced sputum in mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Increased levels of RANTES in induced sputum of chronic asthma but not in seasonal grass pollen-induced rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 476s
Year: 2003

The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Induced sputum free interleukin-5 level and its mRNA expression in atopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Recruitment of eosinophils and increased expression of mast cells tryptase in the bronchial mucosa of patients with allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002

Establishing the effects of chronic exposure to IL-9 alone and in combination with IL-13 on the differentiation of asthmatic and non-asthmatic paediatric bronchial epithelial cells
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009